Answer
Blincyto (blinatumomab) is contraindicated in patients with hypersensitivity to blinatumomab or any of its excipients.
Sources for this answer
- BLINCYTO 38.5 micrograms powder for concentrate and solution for solution for infusionAmgen Ltd · emc · SmPC §4.3 Contraindications · Version 25Document updated
Sources checked